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To identify a candidate etiologic agent for turkey viral 
hepatitis, we analyzed samples from diseased turkey 
poults from 8 commercial fl ocks in California, USA, that 
were collected during 2008–2010. High-throughput 
pyrosequencing of RNA from livers of poults with turkey 
viral hepatitis (TVH) revealed picornavirus sequences. 
Subsequent cloning of the ≈9-kb genome showed 
an organization similar to that of picornaviruses with 
conservation of motifs within the P1, P2, and P3 genome 
regions, but also unique features, including a 1.2-kb 
sequence of unknown function at the junction of P1 and 
P2 regions. Real-time PCR confi rmed viral RNA in liver, 
bile, intestine, serum, and cloacal swab specimens from 
diseased poults. Analysis of liver by in situ hybridization 
with viral probes and immunohistochemical testing of 
serum demonstrated viral nucleic acid and protein in livers 
of diseased poults. Molecular, anatomic, and immunologic 
evidence suggests that TVH is caused by a novel 
picornavirus, tentatively named turkey hepatitis virus.
Turkey viral hepatitis (TVH) is a highly infectious disease affecting young turkey poults. The disease is 
often subclinical, causing minor histologic lesions, and 
becomes overt when the animals are stressed, resulting in 
varying rates of illness and death (1). Mortality rates of 
up to 25% have been reported (2). Diagnosis is based on 
characteristic lesions in the liver, which include multifocal 
necrosis and mononuclear infl ammatory cell infi ltrates 
(3,4). Similar lesions may be found in the pancreas. Clinical 
signs include anorexia, depression, diarrhea, and weight 
loss compatible with a diagnosis of enteritis, the second 
most common diagnosis made in turkey poults throughout 
the United States. Although we cannot with confi dence 
estimate the specifi c burden of TVH, its economic effects 
are likely substantial; in the United States, turkey production 
was valued at $3.71 billion in 2007. The identifi cation of a 
pathogen and development of specifi c diagnostics will lead 
to better understanding of the economic consequences and 
other effects of TVH.
The disease has been experimentally reproduced in 
turkey poults by inoculation with material derived from 
affected animals (1–4). A viral basis for TVH has been 
presumed since its initial description in 1959 because 
the causative agent passed through 100-nm membranes, 
was acid stable, was not affected by antimicrobial drugs, 
and could be propagated in the yolk sac of embryonated 
chicken eggs (3–5). Icosahedral particles of 24  to 30 nm 
have been found by electron microscopy (EM) in liver 
lesions of birds (6) as well as in embryonated turkey eggs 
(1) that have been inoculated with material derived from 




Samples from healthy and diseased turkey poults 
were collected from February 2008 through January 2010 
from 8 commercial fl ocks in California, USA. Flock sizes 
ranged from 22,500 to 40,000 birds. Clinical signs in 
diseased poults included anorexia, lethargy, diarrhea, and 
increased mortality rates. Postmortem analyses revealed 
livers with white foci and, occasionally, pale patchy areas 
in the pancreas. Histopathologic examination showed 
necrosis of hepatocytes and acinar cells of the pancreas and 
infl ammation.
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High-throughput Pyrosequencing
Total RNA was extracted from 4 sick 25-day-old 
turkey poults by using TRI Reagent (Molecular Research 
Center, Inc. Cincinnati, OH, USA) and treated with DNaseI 
(Ambion, Austin, TX, USA). Two micrograms of DNaseI-
treated RNA was reverse transcribed by using Superscript 
II (Invitrogen, Carlsbad, CA, USA) and random octamer 
primers with an arbitrary specifi c anchor sequence as 
described previously (9). cDNA was RNase H-treated 
before random amplifi cation by PCR. The resulting 
products were purifi ed by using MinElute (QIAGEN, 
Hilden, Germany) and ligated to linkers for sequencing 
on a GSL FLX Sequencer (454 Life Sciences, Branford, 
CT, USA). Sequences were clustered and assembled into 
contiguous fragments (contigs) after trimming of primer 
sequences, and BLAST analysis was applied to compare 
contigs (or single reads) at the nucleotide  and amino acid 
levels to the GenBank database (www.ncbi.nlm.nih.gov).
PCR and Genome Sequencing
Primers were designed that bridged contigs identifi ed 
by high-throughput sequencing. Additional primers were 
selected to resequence the genome with special attention 
to junctions of the P1 and P2 regions. The PCRs were 
conducted by using HotStar polymerase (QIAGEN) 
primers at 0.2 μmol/L each and 1 μL of random hexamer-
primed cDNA. The draft genome sequence was confi rmed 
by selecting additional primers to generate ≈1 kb products 
across the entire sequence for direct dideoxy sequencing 
(Genewiz, South Plainfi eld, NJ, USA), applying TaKaRa 
LA Taq polymerase with GC buffer (TaKaRa Bio, Otsu, 
Japan) to obtain products in areas that proved diffi cult 
to amplify because of potential secondary structures or 
elevated GC content.
Quantitative TaqMan Real-time PCR
Primers and probes for quantitative real-time PCR 
were selected within the 5′ untranslated region (UTR) 
of the turkey hepatitis virus (THV) genome by using 
Primer Express 1.0 software (Applied Biosystems, 
Foster City, CA). The primer/probe set THVforward1 
5′-CACCCTCTAYGGGCAATGT-3′, THVreverse1 5′-TC
AGCCAGTCTATGGCCAGG-3′, and THVprobe1 6FAM-
5 ′-TGGATTCCCATCTCACGCGTCCAC-3 ′-TMR 
used in assay 1 (Table 1) was chosen on the basis of the 
initial THV strains sequenced. Primer THVforward2 
5′-CACCCTYYAYGGGCAAATGT-3′ and probe THV
probe2 6FAM-5′-ATTCCCATCTCACGCGTCCAC-3′-
TMR were later selected to address sequence variation of 
additional strains and used with THVreverse1 primer in 
assay 2 (Table 2). A calibration standard for both assays 
was generated from strain 2993A by cloning a 571-nt 
genomic fragment into the pGEM-T Easy vector (Promega 
Corp., Madison, WI, USA). PCRs were pursued in triplicate 
by using a StepOnePlus Real-time PCR system (Applied 
Biosystems), and a standard cycling profi le of 45 cycles 
in a volume of 25 μL containing random hexamer-primed 
cDNA, 300 nmol/L primer (each), and 200 nmol/L probe. 
Results were expressed as mean copy number per 300 ng 
total RNA.
Phylogenetic Analysis
Phylogenetic analyses were performed based on THV 
P1, 2C/3C/3D, and full polyprotein sequence excluding 
divergent aa 799–1199. Sequences were aligned to selected 
members of the Picornaviridae family by ClustalW and 
trees were constructed by using the Molecular Evolutionary 
Genetics Analysis (MEGA) software version 4.0.2 (10). 
A Jukes-Cantor model was applied to calculate distance, 
and statistical signifi cance was assessed by bootstrap 
resampling of 1,000 pseudoreplicate datasets.
In Situ Hybridization
Viral probes and β-actin control probes were designed 
and applied according to the QuantiGene ViewRNA 
protocol by using branched DNA technology (Panomics, 
Fremont, CA, USA). Twenty viral probes, 17–28 nt long, 
were selected that cover 500 nt of target sequence in 2B/2C. 
Forty β-actin probes, 17–26 nt long, were selected covering 
873 nt of mRNA sequence. Five-micrometer–thick paraffi n-
embedded tissue sections were fi xed, permeabilized with 
protease, and hybridized with oligonucleotides conjugated 
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Table 1. Real-time PCR measurement of viral sequences in 
organ samples from turkey poults with turkey viral hepatitis 
compared with controls, California, USA, 2008–2010* 
Poult no. Age, d Organ  Ct Virus copies†
Infected
 2993A 25 Liver 17.12 5.66 × 107
 2993B 25 Liver 17.02 6.22 × 107
 2993C 25 Liver 26.98 9.0 × 103
 2993D 25 Liver 17.93 2.8 × 107
 0091.1 28 Liver 17.24 5.1 × 10 
 0091.2 28 Liver 17.69 3.43 × 107
 0091.3 28 Liver 23.26 2.57 × 105
 1813.1 26 Liver 23.48 2.12 × 105
 1813.2 26 Liver 21.23 1.53 × 106
 1813.3 26 Intestine 20.94 1.97 × 106
 0690 30 Liver 34.92 8.98 × 10° 
 1999 29 Liver 28.44 8.42 × 103
Pancreas 25.97 7.32 × 104
Intestine 24.85 1.96 × 105
Control 
 1621.1 42 Liver >36‡ Negative
 1621.2 42  Liver >36‡ Negative
 1621.3 42 Liver >36‡ Negative
*Ct, cycle threshold. 
†In 300 ng total RNA. Copy numbers were calculated on the basis of a 
standard curve generated from cloned target sequences. 
‡Ct >36 was rated as negative on the basis of the highest dilution of 
standard representing 5 copies. 
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to alkaline phosphatase. After incubation with FastRed 
substrate, the slides were counterstained with hematoxylin 
and mounted with coverslips by using Permount (Fisher 
Scientifi c, Pittsburgh, PA, USA). Images were acquired by 
using a Zeiss AX10 Scope AI, ProgRes digital microscope 
camera and Mac Capture Pro 2.6.0 software (Jenoptik, 
Jena, Germany).
Immunohistochemical Analysis
Glass slides with embedded tissues were heated at 
56°C for 10 min and washed in citrus clearing agent (Fisher 
Scientifi c) to remove paraffi n. The sections were rehydrated 
through graded alcohol solutions. Endogenous peroxidase 
activity was blocked by incubation in 0.3% H2O2 diluted 
in methanol for 30 min. Nonspecifi c binding was blocked 
by incubating sections in 10% goat serum in phosphate-
buffered saline (PBS) for 1 h at 37°C. Serum specimens from 
poults with or without disease were added to the sections 
at 1:1,000 dilutions in PBS for overnight incubation at 4°C. 
After being washed in PBS, horseradish peroxidase–labeled 
goat anti-turkey immunoglobulin G (KPL, Gaithersburg, 
MD, USA) was added at a 1:250 dilution in PBS for 1 h 
at 37°C. After PBS washes, the Vectastain Elite ABC kit 
(Vector Laboratories, Burlingame, CA, USA) was used, 
with 3, 3′-diaminobenzidine tetrahydrochloride as substrate 
(ImmPACT DAB kit; Vector Laboratories). The sections 
were counterstained with hematoxylin and dehydrated 
through graded alcohols. Finally, the slides were mounted 
with coverslips by using Permount (Fisher Scientifi c) and 
examined under a Zeiss AX10 Scope AI light microscope 
at ×40 magnifi cation (Jenoptik).
Results
Identifi cation of THV
Unbiased high-throughput pyrosequencing of RNA 
extracted from livers of 4 poults with TVH (animals 2993A, 
2993B, 2993C, and 2993D; Table 1) yielded ≈63,100 
sequence reads with a mean length of 285 nt. Seven contigs 
(average length of 674 nt, comprising 105 sequence reads) 
and 2 singletons (read lengths of 486 nt and 498 nt) that 
together yielded 3,182 nt of sequence were identifi ed after 
primer trimming and assembly. Analysis at the nucleotide 
level was not informative; however, BLASTx analysis 
revealed signifi cant similarity to picornavirus sequences 
at the amino acid level. The remainder of the genome 
was determined from RNA of poult 2993D by RT-PCR 
with primers linking the individual contigs and singletons 
(Figure 1). Applying additional primers in various genome 
regions, a second 9-kb genomic sequence was generated 
from another diseased poult (animal 0091.1). Sequence 
analysis showed that the second strain had the same genome 
organization as strain 2993D and 96.8% aa and 89.9% nt 
sequence identity (GenBank accession nos. HM751199 
and HQ189775).
THV Genome Organization
The THV genome, comprising >9,040 nt and 2,813 
aa, is larger than that of equine rhinitis B virus (genus 
Erbovirus), the largest known picornavirus genome 
(11). The length chiefl y refl ects the presence of a 1.2-kb 
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Table 2. Real-time PCR measurement of viral sequences in 
samples from turkey poults with turkey viral hepatitis compared 
with controls, California, USA, 2008–2010* 
Poult no. Age, d Sample Ct Virus copies†
Infected
 2641.1 29 Cloacal swab 21.68 2.28 × 107
Bile 31.44 7.58 × 104
Serum 43.12 1.2 × 102
 2641.2 29 Cloacal swab >44‡ Neg 
Bile 32.5 4.04 × 104
Serum 38.04 1.67 × 103
 2641.3 29 Cloacal swab >44‡ Neg 
Bile 28.60 3.84 × 105
Serum 34.18 1.55 × 104
 2641.4 29 Cloacal swab 30.6 1.21 × 105
Bile 27.72 6.48 × 105
Serum 41.06 3.06 × 102
 2641.5 29 Cloacal swab 28.11 5.09 × 105
Bile 32.8 5.84 × 104
Serum 41.33 2.71 × 102
 394.1 28 Cloacal swab >44‡ Neg 
Serum 43.27 8.17 × 101
 394.2 28 Cloacal swab 40.7 4.55 × 102
Serum >44‡ Neg 
 394.3 28 Cloacal swab >44‡ Neg 
Serum >44‡ Neg 
 394.4 28 Cloacal swab 29.62 2.14 × 105
Serum >44‡ Neg 
 394.5 28 Serum >44‡ Neg 
 394.6 28 Serum >44‡ Neg 
 394.7 28 Serum >44‡ Neg 
 394.8 28 Serum >44‡ Neg 
 394. 9 28 Serum 31.07 9.34 × 104
 3302.1 39 Serum 36.38 3.08 × 103
 3302.2 39 Serum >44‡ Neg 
 3302.3 39 Serum >44‡ Neg 
 3302.5 39 Serum >44‡ Neg 
Control 
 2491.1 32 Cloacal swab >44‡ Neg 
 2491.2 32 Cloacal swab 25.67 2.2 × 106
 2491.3 32 Cloacal swab >44‡ Neg 
 2491.4 32 Cloacal swab >44‡ Neg 
 2491.5 32 Cloacal swab >44‡ Neg 
 2491.6 32 Cloacal swab 34.74 1.11 × 104
 407.1 39 Cloacal swab >44‡ Neg 
 407.2 39 Cloacal swab >44‡ Neg 
 407.3 39 Cloacal swab >44‡ Neg 
 407.4 39 Cloacal swab >44‡ Neg 
*Ct, cycle threshold; neg, negative. 
†In 300 ng total RNA. Copy numbers were calculated on the basis of a 
standard curve generated from cloned target sequences. 
‡Ct >44 was rated as negative on the basis of the highest dilution of 
standard representing 5 copies. 
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sequence at the junction of the P1 and P2 regions in an 
otherwise typical picornavirus genome (Figure 1). The 
incomplete 461-nt 5′ UTR includes a 30-nt motif (nt 
270–300 of THV) that is identical to duck hepatitis A 
virus 5′ UTR (Avihepatovirus genus), which has a type IV 
internal ribosome entry site. However, Mfold-modeling of 
the available sequence did not allow identifi cation of the 
internal ribosome entry site type present in THV. At the 3′ 
end, 140 nt of the UTR were recovered (without reaching 
a poly-A tail) that showed no sequence similarity to other 
picornavirus 3′ UTRs.
With the exception of a highly conserved Gxxx[T/S] 
motif (12) that in some picornaviruses permits 
myristoylation, little sequence conservation occurs in 
the VP0 of THV with respect to other picornaviruses. 
Cleavage at an upstream Q73/A would not generate an 
N terminal G, cleavage at this site is not supported by 
NetPicoRNA prediction, and the presence of a leader 
sequence is unclear (Figure 1; www.cbs.dtu.dk/services/
NetPicoRNA). Therefore, as in parechoviruses, hepatitis 
A virus, and avian encephalomyelitis virus, this site 
is probably not functional for myristoylation in THV 
(13–15). NetPicoRNA analysis did not indicate a VP2/4 
maturation cleavage as found in avihepatoviruses, 
kobuviruses, and parechoviruses. Sequence comparisons 
of the P1 region, mainly driven by recognizable sequence 
conservation in VP3 and a few regions in VP1, indicate 
the highest amino acid identity (20%) with turdiviruses, 
unclassifi ed picornaviruses recently identifi ed from wild 
birds (16). Homology in P1 to pfam sequence cluster 
cd00205 “picornavirus capsid protein domain like” 
(GenBank accession no. PF00073) was observed between 
amino acid residues 109–267, 391–539, and 622–768 
(Figure 1). Potential cleavage sites within P1 are predicted 
after Q388 (VP0/3) and Q554 (VP3/1).
Protein 2A motifs in THV are conserved with respect 
to kobuviruses after a predicted cleavage site Q1199. 
However, the sequence lacks the trypsin-like protease 
motifs that allow autocatalytic cleavage at the N-termini 
of enteroviruses and sapeloviruses, as well as the NPGP 
motif that facilitates C-terminal cleavage in aphthoviruses, 
avihepatoviruses, cardioviruses, erboviruses, senecaviruses, 
and teschoviruses. The predicted 2A sequence of THV 
resembles Hbox-NC motifs in hepatoviruses, kobuviruses, 
parechoviruses, and tremoviruses (H1250WGI, N1310C 
followed by a hydrophobic region L1332-V1350). The THV 2A 
protein may be generated by cleavage at conserved protease 
sites; however, multiple cleavage sites between P1 and P2 
are predicted by NetPicoRNA (Figure 1). Cleavage after Q798 
and Q1199 appears likely because it would generate VP1 and 
2A products that align with other picornavirus proteins. As 
a result, 1 or 2 additional proteins (depending on cleavage 
at Q880, Figure 1) may be produced from this genome region 
that have no homology to any viral product recorded in 
GenBank. Multiple 2A1, 2A2, or 2A3 protein products 
with undefi ned function are described in Ljungan virus, seal 
picornavirus, and duck hepatitis virus genomes (17–19). 
Although we predict, based on alignment analyses, that the 
C-terminal cleavage of 2A occurs at Q1398, this prediction 
is poorly supported by NetPicoRNA. 2B and 2C have 
sequence homology to kobuvirus sequences, particularly in 
a conserved 2C helicase domain G1724SPGVGKS that aligns 
to the PF00910 RNA helicase domain.
Although no sequence homology to any picornavirus 
record in GenBank was found for THV 3A, 3B displays 
a conserved tyrosine in position 3 as well as a conserved 
glycine in position 5. The THV 3C protease contains the 
active site motif G2298MCGA, which is consistent with 
3C proteases of other picornaviruses, and shows highest 
homology to cosaviral 3C (PF00548 3C cysteine protease 
[picornain] aligning to aa 2153–2321, Figure 1). The 
identity of a 472-aa sequence at the 5′ end of the genome 
as THV 3D is supported by homology of aa 2355–2809 
to PF00680 RNA-dependent RNA polymerases, and the 
conservation of positive-strand viral RNA-dependent RNA 
polymerase motifs A–E (20) (Figure 1).
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Figure 1. Predicted turkey hepatitis 
virus (THV) genome organization 
based on sequence comparison to 
known picornaviruses. Dotted lines 
above the genome depict the location 
of the original sequences obtained by 
high-throughput sequence analysis. 
Conserved picornaviral motifs and 
predicted potential cleavage sites 
along the coding region are indicated 
in the bar below. 
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The assembled THV genome sequences were used 
to reanalyze the initial read library generated by unbiased 
high-throughput pyrosequencing. This analysis confi rmed 
the presence, and overlap with, the adjacent sequences of 
divergent 2A and 3A region reads in the initial dataset.
Phylogenetic analyses based on amino acid sequence 
of the most informative genome regions 2C/3C/3D, the 
P1 region, and the full polyprotein sequence (excluding 
the nonconserved aa 799–1199) showed THV as a distinct 
species separate from classifi ed genera (Figure 2). The 
2C/3C/3D analysis indicates THV in an ancestral position 
to kobuviruses, klasseviruses, and turdiviruses, the viruses 
most related to THV.
THV RNA Load in Liver, Bile, Serum, 
and Cloacal Swab Specimens
Two TaqMan real-time PCR assays, both targeting the 
5′ UTR, were developed to quantitate viral RNA load in 
affected animals. Assay 1 (Table 1) was replaced by assay 
2 (Table 2) after the characterization of additional THV 
strains indicated divergent sequences.
In the liver samples from turkeys with TVH, viral 
RNA typically exceeded 105 copies/300 ng of total RNA; 
only 1 animal had a lower load (animal 0690, Table 1). 
No viral RNA was detected in livers from non-diseased 
control animals. Analysis of animals 1813.3 and 1999 
indicated presence of the virus in the intestine and pancreas 
as well as in the liver. Cloacal swab samples, bile, and 
serum from 28-, 29- and 39-day-old poults with disease 
were also analyzed. Five of 9 cloacal swab specimens from 
TVH-affected animals were positive for viral RNA (Table 
2). Viral RNA >104 copies/300 ng total RNA was detected 
in the bile of all 5 poults with TVH tested. Viral RNA was 
also found in serum samples from 8 of 18 poults with TVH.
Cloacal swabs were analyzed from 32- and 39-day-
old turkey poults that did not have TVH according to 
histopathologic fi ndings. Viral RNA was detected  in 2 of 
10 animals tested (Table 2).
Localization of THV RNA and Protein in Liver
The distribution of THV RNA was examined in 
liver sections of affected and unaffected poults by in situ 
hybridization. THV signal was found in the cytoplasm of 
hepatocytes of affected poults. No signal was observed 
in healthy poults (Figure 3). A hybridization signal with 
a control β-actin probe was present in both affected and 
healthy poults; however, β-actin signal was less pronounced 
in affected poults. In situ hybridization also indicated viral 
RNA in 1 intestinal sample from the 0091 animals (not 
shown), in line with the real-time PCR data obtained for 
animals 1813.3 and 1999 (Table 1).
Serum from TVH-affected poult 394.9, which was 
positive by PCR for THV RNA (Table 2), was used on 
paraffi n-embedded tissues for immunohistochemical 
analysis. The serum showed reactivity when tested in livers 
from affected poults. No reactivity was observed with 
healthy poults (Figure 4).
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Figure 2. Relationships between turkey hepatitis virus (THV) and other picornaviruses. The phylogenetic analyses were based on amino 
acid sequences of the combined 2C, 3C, and 3D regions (A), the P1 region (B), and complete coding regions, excluding divergent aa 
799–1199 (C). Representative sequences from different picornavirus genera and recently discovered, unclassifi ed viruses were obtained 
from GenBank; accession numbers are indicated. Bootstrap values are given at the respective nodes; scale bars indicate number of 
amino acid substitutions per site. TMEV, Theiler’s murine encephalomyelitis virus; EMCV, encephalomyocarditis virus; SVV, Seneca Valley 
virus; HCoSV-A1, human cosavirus A1; HCoSV-D1, human cosavirus D1; ERBV, equine rhinitis B virus; ERAV, equine rhinitis A virus; 
BRBV, bovine rhinitis B virus; FMDV, foot-and-mouth disease virus; PTV, porcine teschovirus; PSV, porcine sapelovirus; SSV, simian 
sapelovirus; ASV, avian sapelovirus; HRV-C, human rhinovirus C; CV-A21, coxsackievirus A21; EV-96, enterovirus 96; TV-2, turdivirus 2; 
TV-3, turdivirus 3; TV-1, turdivirus 1; AiV, Aichi virus; BKV, bovine kobuvirus; PKV, porcine kobuvirus; AEV, avian encephalomyelitis virus; 
HAV, hepatitis A virus; SePV, seal picornavirus; DHAV, duck hepatitis A virus; HPeV, human parechovirus; LV, Ljungan virus. 
Novel Picornavirus in Poults with Hepatitis
Discussion
The Picornaviridae, a family of small, nonenveloped 
viruses with a positive-sense, single-strand RNA genome, 
currently consist of 12 genera. Recent additions to the 
family include salivirus NG-J1 and human klasseviruses 
identifi ed in pediatric stool samples (21–23), cosaviruses 
(24,25), and an unclassifi ed seal picornavirus 1 (17). 
Our phylogenetic analyses indicate that THV, although 
distantly related to viruses of the Kobuvirus genus as 
well as to unclassifi ed klasseviruses/saliviruses and 
recently identifi ed turdiviruses, is distinct from known 
picornaviruses.
Most peculiar is the unique 2A region of THV. THV 
appears to encode multiple 2A products. Although multiple 
2A products have also been described for Ljungan virus, 
seal picornavirus, and duck hepatitis virus (17–19), the 
2A region of THV shows no sequence homology to these 
products or to any other picornavirus sequence currently 
in GenBank. Also remarkable is the lack of sequence 
homology of THV 3A to picorna- or other virus sequences. 
Whereas VP3 (representing P1) is closest to turdivirus 1 
(30% aa identity), 2B/C (representing P2) is closer to 
Aichi virus (28%) and 3C/D (representing P3) is closer 
to turdivirus 3 (39%). Thus, THV shows classic features 
of known picornaviruses but also unique features that do 
not support inclusion of THV into existing taxa of the 
Picornaviridae family.
Turkey poults with TVH may have diarrhea and 
pancreatitis as well as hepatitis. Picornavirus particles 
in the feces of animals with TVH have been described 
(26,27). Accordingly, we detected THV RNA in the 
intestine, pancreas, bile, and cloaca samples as well as the 
liver. These fi ndings are consistent with a fecal–oral route 
for transmission. We also detected THV RNA in cloacal 
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Figure 3. Results of in situ hybridization experiments. Hybridization of β-actin–specifi c and turkey hepatitis virus (THV)–specifi c 
oligonucleotide probes with FastRed staining on hepatitis-affected liver tissue from poult 2993A (A and B, respectively) and on nondiseased 
liver tissue from poult 1927B (C and D, respectively). Brightfi eld microscopy images; original magnifi cation ×40. 
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swab samples from 2 of 10 asymptomatic poults. Because 
these animals were housed on a farm with history of TVH, 
this fi nding is consistent with reports suggesting subclinical 
infections (2,6). The advent of a noninvasive screening test 
for THV may aid in disease containment.
We molecularly characterized a picornavirus in 
turkey viral hepatitis and linked it to disease through 
measurements of load and tissue distribution, viremia and a 
humoral immune response to the agent. On the basis of the 
data presented here, we suggest that THV represents a new 
species in the order Picornavirales and a likely candidate 
for causing TVH.
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